Mechanisms and markers of vascular damage in ANCA-associated vasculitis

Autoimmunity

Volumn 42, Issue 7, 2009, Pages 605-614

  Haubitz, Marion ^a   Dhaygude, Ajay ^b   Woywodt, Alexander ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ANCA associated vasculitis; Autoimmunity; Circulating endothelial cells; Endothelium; Vascular damage

Indexed keywords

ANCA ASSOCIATED VASCULITIS; APOPTOSIS; BLOOD VESSEL INJURY; CELL ACTIVATION; ENDOTHELIAL MICROPARTICLE; PATHOGENESIS; RESPIRATORY BURST; REVIEW; VASCULAR DISEASE;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; BLOOD VESSELS; ENDOTHELIAL CELLS; HUMANS; THROMBOSPONDIN 1;

EID: 71049189995     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930903002503     Document Type: Review

References (100)

1. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? Br Med J (Clin Res Ed) 1982;285:606.
2. Jennette JC, Falk RJ. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol 2008;20:55-60.
3. Pankhurst T, Savage CO, Little MA. Review article: Leukocyte-endothelial dysregulation in systemic small vessel vasculitis. Nephrology (Carlton) 2009.
4. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007;170:52-64.
5. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 2009;20:289-298.
6. Brons RH, de Jong MC, de Boer NK, Stegeman CA, Kallenberg CG, Tervaert JW. Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann Rheum Dis 2001;60:1097-1102.
7. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993;36: -1371.
8. Ding M, Cui S, Li C, et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 2006;12:1081-1087.
9. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:743-753.
10. Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002;110: -1963.
11. Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005;45: -1761.
12. Clayton AR, Savage CO. Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis. Clin Exp Immunol 2003;132:174-179.
13. Golbin JM, Specks U. Targeting B lymphocytes as therapy for ANCA-associated vasculitis. Rheum Dis Clin North Am 2007;33:741-754. (Pubitemid 350122977)
14. Lovric S, Erdbruegger U, Kumpers P, et al. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibodyassociated vasculitis: A single-centre experience with 15 patients. Nephrol Dial Transplant 2009;24:179-185.
15. Hogan SL, Cooper GS, Savitz DA, et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: A population-based, case-control study. Clin J Am Soc Nephrol 2007;2:290-299.
16. Bartunkova J, PelclovaD, Fenclova Z, et al. Exposure to silica and risk of ANCA-associated vasculitis. Am J Ind Med 2006;49:569-576.
17. Kallenberg CG, Tadema H. Vasculitis and infections: Contribution to the issue of autoimmunity reviews devoted to 'autoimmunity and infection'. Autoimmun Rev 2008; 8:29-32.
18. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-17.
19. Schultz H. From infection to autoimmunity: A new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev 2007;6:223-227.
20. Aichele D, Schnare M, Saake M, Rollinghoff M, Gessner A. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect Immun 2006;74:4708-4714.
21. Pendergraft WF, 3rd, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004;10:72-79.
22. Hurtado PR, Jeffs L, Nitschke J, et al. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol 2008;9:34.
23. Csernok E, Holle JU, Gross WL. Proteinase 3, proteaseactivated receptor-2 and interleukin-32: Linking innate and autoimmunity in Wegener's granulomatosis. Clin Exp Rheumatol 2008;26:S112-S117.
24. Jennifer L, Gommerman MCC. Negative selection of B lymphocytes: A novel role for innate immunity. Immunol Rev 2000;173:120-130.
25. Cohen S. New interpretation of vasculitis in the light of evolution. Am J Med Sci 2008;335:469-476.
26. Blann AD, Woywodt A, Bertolini F, et al. Circulating endothelial cells: Biomarker of vascular disease. Thromb Haemost 2005;93:228-235. (Pubitemid 40253726)
27. Bardin N, George F, Mutin M, et al. S-Endo1, a panendothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996;48:531-539.
28. Woywodt A, Kirsch T, Haubitz M. Immunomagnetic isolation and FACS-competing techniques for the enumeration of circulating endothelial cells. Thromb Haemost 2006; 96:1-2.
29. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003;' 361:206-210. (Pubitemid 36126220)
30. Erdbruegger U, Haubitz M, Woywodt A. Circulating endothelial cells: A novel marker of endothelial damage. Clin Chim Acta 2006;373:17-26. (Pubitemid 44292176)
31. Mancuso P, Calleri A, Cassi C, et al. Circulating endothelial cells as a novel marker of angiogenesis. Adv Exp Med Biol 2003;522:83-97. (Pubitemid 36570529)
32. Mariucci S, Rovati B, Chatzileontiadou S, et al. A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells. Scand J Clin Lab Invest 2009:1-6.
33. Woywodt A, Blann AD, Kirsch T, et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: Proposal of a definition and a consensus protocol. J Thromb Haemost 2006;4:671-677.
34. Woywodt A, Erdbruegger U, Haubitz M. Circulating endothelial cells and endothelial progenitor cells after angioplasty: News from the endothelial rescue squad. J Thromb Haemost 2006;4:976-978.
35. Duda DG, Cohen KS, Scadden DT, Jain RK. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007;2:805-810.
36. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999;93: -12958.
37. Nadar SK, Lip GY, Lee KW, Blann AD. Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost 2005;94:707-712.
38. Smadja DM, Gaussem P, Mauge L, et al. Circulating endothelial cells: A new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 2009;119:374-381.
39. Dang A, Wang B, Li W, et al. Plasma endothelin-1 levels and circulating endothelial cells in patients with aortoarteritis. Hypertens Res 2000;23:541-544.
40. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T, Sekine I. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 2003;131:536-540.
41. Clancy RM. Circulating endothelial cells and vascular injury in systemic lupus erythematosus. Curr Rheumatol Rep 2000;2:39-43.
42. Foster W, Shantsila E, Carruthers D, Lip GY, Blann AD. Circulating endothelial cells and rheumatoid arthritis: Relationship with plasma markers of endothelial damage/ dysfunction. Rheumatology (Oxford) 2009;48:285-288.
43. Erdbruegger U,Woywodt A, Kirsch T, Haller H, Haubitz M. Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy. Am J Kidney Dis 2006; 48: -1570.
44. Haubitz M, Woywodt A. Circulating endothelial cells and vasculitis. Intern Med 2004;43:660-667.
45. Woywodt A, Goldberg C, Kirsch T, et al. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA-associated vasculitis. Ann Rheum Dis 2005; 65:164-168.
46. Brogan PA, Shah V, Brachet C, et al. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 2004;50:927-936.
47. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009;335:143-151.
48. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cellderived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009;101:439-451.
49. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: -11851.
50. Hamilton KK, Hattori R, Esmon CT, Sims PJ. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990; 265: -13814.
51. ErdbrueggerU, Grossheim M, Hertel B, et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford) 2008;47:1820-1825.
52. Faure V, Dou L, Sabatier F, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006;4:566-573.
53. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007;66:159-165.
54. Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998;161:4382-4387.
55. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 1999;274: -123118.
56. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002;99:3962-3970.
57. Lacroix R, Sabatier F, Mialhe A. Activation of plasminogen into plasmin at the surface of endothelial microparticles: A mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 2007;110: -12439.
58. AbidHusseinMN,BoingAN, SturkA,HauCM,NieuwlandR. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 2007;98: -11107.
59. Barry OP, PraticoD, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102:136-144.
60. Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000;95:1317-1323.
61. Hobson B, Denekamp J. Endothelial proliferation in tumours and normal tissues: Continuous labelling studies. BrJ Cancer 1984;49:405-413.
62. Caplan BA, Schwartz CJ. Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis 1973;17:401-417.
63. Dimmeler S, Hermann C, Galle J, Zeiher AM. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 1999;19: -1664.
64. Muller-Marschhausen K, Waschke J, Drenckhahn D. Physiological hydrostatic pressure protects endothelial monolayer integrity. Am J Physiol Cell Physiol 2008;294: C324-C332.
65. Re F, Zanetti A, Sironi M, et al. Inhibition of anchoragedependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994;127:537-546.
66. Philippova M, Ivanov D, Allenspach R, Takuwa Y, Erne P, Resink T. RhoA and Rac mediate endothelial cell polarization and detachment induced by T-cadherin. FASEB J 2005; 19: -1590.
67. Ma Z, Liu Z, Myers DP, Terada LS. Mechanotransduction and anoikis: Death and the homeless cell. Cell Cycle 2008;7: -12465.
68. Ballieux BE, Hiemstra PS, Klar-Mohamad N, et al. Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol 1994;24:3211-3215.
69. Yang JJ, Kettritz R, Falk RJ, Jennette JC, Gaido ML. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol 1996; 149:1617-1626.
70. Viemann D, Barczyk K, Vogl T, et al. MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program. Blood 2007;109: -12460.
71. Rolland Y, Demeule M, Beliveau R. Melanotransferrin stimulates t-PA-dependent activation of plasminogen in endothelial cells leading to cell detachment. Biochim Biophys Acta 2006;1763:393-401.
72. Haubitz M, Gerlach M, Kruse HJ, Brunkhorst R. Endothelial tissue factor stimulation by proteinase 3 and elastase. Clin Exp Immunol 2001;126:584-588.
73. Bombeli T, Muller M, Straub PW, Haeberli A. Cyclosporineinduced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood. J Lab Clin Med 1996;127:621-634.
74. Oliveira-Ferrer L, Hauschild J, Fiedler W, et al. Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway. J Exp Clin Cancer Res 2008;27:86.
75. Woolf AS, Gnudi L, Long DA. Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 2009;20: -1244.
76. Parikh SM, Mammoto T, Schultz A, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006;3:e46.
77. Kumpers P, David S, Haubitz M. The Tie2 receptor antagonist Angiopoietin-2 facilitates vascular inflammation in Systemic Lupus Erythematosus. Ann Rheum Dis 2008 17 October [Epub ahead of print].
78. Kumpers P, Hellpap J, David S. Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement. Nephrol Dial Transplant 2009;24:1845-1850.
79. Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005;46:7-18.
80. Mobius-Winkler S, Hollriegel R, Schuler G, Adams V. Endothelial progenitor cells: Implications for cardiovascular disease. Cytometry A 2009;75:25-37.
81. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau. Atherosclerosis 2008;197:496-503.
82. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
83. Eilken HM, Nishikawa S, Schroeder T. Continuous singlecell imaging of blood generation from haemogenic endothelium. Nature 2009;457:896-900.
84. de Groot K, Goldberg C, Bahlmann FH, et al. Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2007;56:3847-3853.
85. Avouac J, Juin F, Wipff J, et al. Circulating endothelial progenitor cells in systemic sclerosis: Association with disease severity. Ann Rheum Dis 2008;67:1455-1460.
86. Holmen C, Elsheikh E, Stenvinkel P, et al. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 2005;16:3110-3120.
87. Zavada J, Kideryova L, Pytlik R, Vankova Z, Tesar V. Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis. Kidney Blood Press Res 2008; 31:247-254.
88. Woywodt A, Bahlmann FH, de Groot K, Haller H, Haubitz M. Circulating endothelial cells: Life, death and detachment of the endothelial cell layer. Nephrol Dial Transplant 2002;17:1728-1730.
89. Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001;166:7128-7135.
90. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;101:890-898.
91. van Rossum AP, Limburg PC, Kallenberg CG. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis. Ann N Y Acad Sci 2005;1051:1-11.
92. Botto M, Dell'Agnola C, Bygrave AE, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-59.
93. Chen Q, Stone PR, McCowan LM, Chamley LW. Phagocytosis of necrotic but not apoptotic trophoblasts induces endothelial cell activation. Hypertension 2006;47: -1121.
94. Kirsch T, Woywodt A, Beese M, et al. Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses. Blood 2007;109:2854-2862.
95. Yang JJ, Preston GA, Alcorta DA, et al. Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). Kidney Int 2002;62:1638-1649.
96. MayetW, Schwarting A, Barreiros AP, Schlaak J, Neurath M. Anti-PR-3 antibodies induce endothelial IL-8 release. Eur J Clin Invest 1999;29:973-979.
97. Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD. Regulation of nitric oxide signalling by thrombospondin 1: Implications for anti-angiogenic therapies. Nat Rev Cancer 2009;9:182-194.
98. Bonnefoy A, Moura R, Hoylaerts MF. The evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell Mol Life Sci 2008;65:713-727.
99. Krisch T, Woywodt A, Klose J, Wyss K, Beese M, Erdbruegger U, Grossheim M, Haller H, Haubitz M. Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance. J Cell Mol Med 2009; June 5 [Epub ahead of print].
100. Woywodt A, Kirsch T, Haubitz M. Circulating endothelial cells in renal disease: Markers and mediators of vascular damage. Nephrol Dial Transplant 2008;23:7-10.